Fundz

Adjuvance Technologies Inc. reported raising $10.7 Million in an initial SEC Form D filing, from an offering of $24.7 Million

PRIVATESep 24, 2019$10.7M of $24.7M raised

Amount Raised

$10.7 Million

$10.7 Million sold, per SEC Form D (first sale Sep 24, 2019)

Round Type

Venture

New YorkOtherBiotechnology

Quick answer

Adjuvance Technologies Inc. raised $10.7 Million in a funding round, dated September 24, 2019. Adjuvance Technologies Inc. is based in New York, New York, United States.

How much did Adjuvance Technologies Inc. raise?
Adjuvance Technologies Inc. raised $10.7 Million in a funding round on September 24, 2019.
What does Adjuvance Technologies Inc. do?
Adjuvance is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing.
Where is Adjuvance Technologies Inc. based and how big is it?
Adjuvance Technologies Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Adjuvance Technologies Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at Adjuvance Technologies Inc., and when

A new round usually means Adjuvance Technologies Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adjuvance Technologies Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adjuvance Technologies Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adjuvance Technologies Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adjuvance Technologies Inc.

Location

1225 L Street, Suite 600

New York, New York, United States

About

Adjuvance is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adjuvance Technologies Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Adjuvance Technologies Inc.'s next move

See what Strategic adds

Adjuvance Technologies Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.